ABUS  220121C00003500

Sold all ABUS $3.50 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Abilash Satya

Bought ABUS $3.50 Calls

ABUS  211217C00005000

Sold ABUS $5 Calls

Zachary Rapp

Arbutus Biopharma Corporation Common Stock

Moderna, Inc. Common Stock

$ABUS owns patent on LNP technology behind basically all mRNA vaccines. Today $MRNA lost appeal against previous patent court ruling against them. Go Arbutus! 🎉🍿

Bought 25% more ABUS $5 Calls

Dakotah

Bought 14% more ABUS $5 Calls

Bought 17% more ABUS $5 Calls

Bought 20% more ABUS $5 Calls

Bought 33% more ABUS $5 Calls

Bought 50% more ABUS $5 Calls

Bought ABUS $5 Calls

ABUS  211217C00002000

Sold all ABUS $2 Calls

Sold 50% of ABUS $2 Calls

Bought 25% more ABUS $2 Calls

Bought 14% more ABUS $2 Calls

Bought 17% more ABUS $2 Calls

Bought 50% more ABUS $2 Calls

Bought 100% more ABUS $2 Calls

Bought ABUS $2 Calls

ABUS  211119P00007500

Sold all ABUS $7.50 Puts

Brian Schardt

arbutus biopharma corporation (nasdaq:abus) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis b infection, a disease of the liver caused by hepatitis